NMTrypI
The NMTrypI (New Medicines for Trypanosomatidic Infections) project aims at obtaining new candidate drugs against Trypanosomatidic infections with appropriate efficiency from the lead phase to the final preclinical phase that are more accessible to patients. The dissemination of infectious diseases due to microorganisms belonging to the Trypanosomatidae family – i.e. trypanosomiasis that causes sleeping sickness, leishmaniasis and Chagas disease – is a very important issue in some areas of the World, including Africa, South America and India, where these parasites are endemic. The NMTrypI Consortium is composed by 13 partners in Europe and in disease-endemic countries (Italy, Greece, Portugal, Sudan, and Brazil).
Our group is hosting the data management for the NMTrypI project and providing custom-built services, all based on the SEEK data management platform.